top of page

Latest News

Keep up with the latest at mDETECT

mDETECT wins 1st place in pitch

competition

Our Co-founder, Dr. Wiginton won the $15,000 USD first place prize

at the LG Innnofest Meeting in San Francisco

September 26, 27, 2024.

lg nova pitch comp2.jpg

mDETECT announces OBIO investment
summit participation

mDETECT will pitch with other seed-stage companies at OBIO
Feb 14 to 16, 2024.

mDETECT featured in >75 newspapers across
Canada and interviewed by Global News

mDETECT founder wins 1st place at

pitch competitions

L2M pitch.jpg

Dr. Wiginton wins first place at the Lab2Market Deep Tech Expo.

capital angel network pitch.jpg

Dr. Wiginton receives first place check at the Capital Angel Network's

#MASHUP Event

Read the mDETECT Impact Story featured

by Mitacs

2023_MitacsImpact vignette_ON_mDETECT_Queens_Irsa Wiginton_LONG_EN.png

mDETECT secures $900k CIHR grant and

launches breast cancer clinical trial

Exciting times for mDETECT and team! Check out our latest press release on our CIHR grant funding and the initiation of the multi-centre breast cancer clinical trial

Join Dr. Wiginton and Dr. Banting discuss

how mDETECT will help cancer patients

In this episode, we interview one of the co-founders of mDetect Inc. - Dr. Irsa Wiginton. Dr. Wiginton holds a PhD in Biochemistry and Cell Biology from Queen's University. mDetect is commercializing a novel 'liquid biopsy' technology to support the treatment of cancer.

Tune in to listen about mDETECT

Dr. Mueller speaks about the mDETECT technology and its impact on cancer patients

genomics.PNG

Pitch Winners!

Both our founders have been successful in several pitch competitions! Check out some of their stories below.

Screenshot 2022-06-23 145408.png

Congrats to Dr. Mueller for winning second place at the Mitacs Invention to Innovation (i2I) Skills Training Final Pitch Competition.

Screenshot 2022-06-23 145435.png

Congrats to Dr. Wiginton for winning first place at the Kingston Syracuse Pathway Pitch Competition.

New mDETECT blood test helps with earlier
cancer detection and better treatment

June 16, 2021: Queen’s researcher Christopher Mueller has developed a breast cancer

detection test that provides real time response to chemotherapy and early detection of relapse.

Research at Queen's University has found a
way to detect cancer through a blood test

The morning show on CKWS

GNM speaks with lead researcher, Christopher Mueller, about the test and how it works.

bottom of page